Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study

NCT: NCT07538609 · NOT_YET_RECRUITING

NCT IDNCT07538609
StatusNOT_YET_RECRUITING
Start Date2026-10-07
Completion2031-05

Brief Summary

This study is a prospective, multicenter, single-arm post-market clinical study to evaluate the GORE® VIABAHN® FORTEGRA Venous Stent in real-world use.

Frequently Asked Questions

What is The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study?

The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study is a clinical trial registered under NCT07538609. Current status: NOT_YET_RECRUITING.

What is the status of NCT07538609?

The current status of NCT07538609 (The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study) is: NOT_YET_RECRUITING.

When did The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study start?

The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study started on 2026-10-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.